Proton Pump Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma (mRCC)

Proton Pump Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma (mRCC)

kidneycancer

3 years
434 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Aly-Khan A. Lalani, Department of Medical Oncology, Cross Cancer Institute, University of Alberta presents Proton Pump Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma (mRCC) at the 2016 annual International Kidney Cancer Symposium.
Up Next Autoplay